Core Viewpoint - The A-share market showed strong performance in August, with major indices rising significantly, yet the excess returns of stock strategy private equity products were disappointing, marking the worst monthly performance of the year [1][2]. Group 1: Market Performance - In August, the Shanghai Composite Index rose by 7.97%, the Shenzhen Component Index increased by 15.32%, and the ChiNext Index surged over 24% [1]. - Despite the strong market, the average excess return of 3,122 stock strategy private equity products was -1.97%, the worst monthly performance this year [1]. Group 2: Quantitative vs. Subjective Strategies - Quantitative private equity products experienced a notable decline, with an average excess return of -3.94% in August, while subjective private equity products had an average excess return of -1.00% [1]. - The significant decline in quantitative products is attributed to a reversal in style, particularly the outperformance of large-cap stocks over small-cap stocks, and severe sector differentiation due to rapid growth in financing scale [1][2]. Group 3: Consistent Performers - As of August 2025, only 95 stock strategy private equity products achieved positive excess returns for eight consecutive months, representing about 3% of the total [2]. - Among private equity firms with over 10 billion in assets, 46 products achieved positive excess returns for eight consecutive months, all of which were quantitative products, with an average excess return of 0.63% in August and 17.91% year-to-date [3]. Group 4: Top Performers by Asset Size - In the 20-100 billion category, 14 products achieved positive excess returns for eight consecutive months, with an average excess return of 1.83% in August and 22.48% year-to-date [7]. - The top three products in this category were "New Thinking Multi-Strategy 3", "Pansong Micro-Cap Index Enhanced 1", and "Giraffe 7", with year-to-date excess returns of ***% [11]. Group 5: Small and Emerging Firms - In the 5-20 billion category, 13 products achieved positive excess returns for eight consecutive months, with an average excess return of 5.34% in August and 57.58% year-to-date [13]. - The leading product in the 0-5 billion category was "Zijin Yunsong", achieving a year-to-date excess return of ***% [18].

Core Viewpoint - The article highlights the significant growth in the quantitative private equity sector, with an increase in the number of top-tier firms and their management scale, driven by the popularity of quantitative investment strategies and market trends [1]. Group 1: Growth of Quantitative Private Equity - As of the end of August 2025, the number of top quantitative private equity firms with management scales exceeding 5 billion yuan has risen to 78, marking an approximate 28% increase from January 2025 [1]. - Among these firms, 45 manage over 10 billion yuan, while 33 have management scales between 5 billion and 10 billion yuan [1]. Group 2: Performance of Top Firms - The top quantitative private equity founders, who are also fund managers, have an average return of 28.81% this year, with an average excess return of 11.12% [1]. - The total number of products managed by these founders that meet ranking criteria is 202, with a combined scale of approximately 28.064 billion yuan [1]. Group 3: Notable Founders and Their Strategies - Xie Xiaoyang, founder of Tianyan Capital, has 12 products with a total scale of approximately 2.174 billion yuan, achieving outstanding excess returns [4]. - Liu Xibin, founder of Hongxi Fund, manages 13 products with a total scale of approximately 1.280 billion yuan, focusing on quantitative trend strategies [7]. - The founders of Heiyi Asset, Zhou Yitian and Chen Zehao, have 21 products with a total scale of approximately 2.419 billion yuan, emphasizing risk control and stable returns [10]. Group 4: Emerging Trends and Innovations - Wu Di, founder of Century Frontier, is focusing on AI developments in quantitative strategies, indicating a shift towards building intelligent systems for strategy development [17].